Comparative research examining PIK3CA mutations in CTCs and matched ctDNA using identical molecular tests and blood samples has demonstrated that PIK3CA hotspot mutations are frequently present in CTCs obtained from CellSearch® cartridges and matched plasma ctDNA in both early- and advanced-stage breast cancer. The gene discussed is PIK3CA; the disease is breast cancer.